LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹109 Cr | ₹106 Cr | ₹107 Cr | ₹133 Cr | ₹145 Cr |
What is the latest Total Non-Current Assets ratio of LYKA LABS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹109 Cr |
| Mar2024 | ₹106 Cr |
| Mar2023 | ₹107 Cr |
| Mar2022 | ₹133 Cr |
| Mar2021 | ₹145 Cr |
How is Total Non-Current Assets of LYKA LABS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹109 Cr | 2.42 | |
| Mar2024 | ₹106 Cr | -1.04 | |
| Mar2023 | ₹107 Cr | -19.56 | |
| Mar2022 | ₹133 Cr | -7.73 | |
| Mar2021 | ₹145 Cr | - | |
Compare Total Non-Current Assets of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹263.2 Cr | -2% | 14.1% | -39.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -2% |
14.1% |
-39.3% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses